Andrew P Hearn - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Andrew P Hearn

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Chest|September 4, 2020

Real-World Effectiveness of Benralizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Andrew P Hearn, Jaideep Dhariwal, et al.

The European Respiratory Journal|February 26, 2021

Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapyAndrew P Hearn, Oliver D Hug, Ziana A Somani, et al.

The European Respiratory Journal|July 20, 2023

The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthmaAlexandra M Nanzer, Victoria Taylor, Andrew P Hearn, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Chest|September 4, 2020

Real-World Effectiveness of Benralizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Andrew P Hearn, Jaideep Dhariwal, et al.

The European Respiratory Journal|February 26, 2021

Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapyAndrew P Hearn, Oliver D Hug, Ziana A Somani, et al.

The European Respiratory Journal|July 20, 2023

The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthmaAlexandra M Nanzer, Victoria Taylor, Andrew P Hearn, et al.

Pageof 2